Michelle C Callegan Selected Research

immune inhibitor A

1/2021

Immune Inhibitor A Metalloproteases Contribute to Virulence in Bacillus Endophthalmitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle C Callegan Research Topics

Disease

32	Infections 01/2021 - 01/2002
25	Endophthalmitis (Ophthalmia) 11/2021 - 01/2002
16	Inflammation (Inflammations) 11/2021 - 05/2002
7	Eye Infections 01/2019 - 01/2002
3	Keratitis 07/2010 - 05/2002
2	Disease Progression 01/2021 - 10/2002
2	Uveitis 10/2020 - 01/2020
1	Blau syndrome 10/2020
1	Bacterial Infections (Bacterial Infection) 11/2017
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016
1	Leukostasis 08/2014
1	Bacteremia 11/2008
1	Ileitis 04/2007
1	Ocular Toxoplasmosis 04/2007
1	Blindness (Hysterical Blindness) 06/2003

Drug/Important Bio-Agent (IBA)

22	Retinaldehyde (Retinal)IBA 11/2021 - 01/2002
6	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 09/2003
6	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 01/2002
6	Explosive Agents (Explosives)IBA 11/2016 - 10/2002
5	Gatifloxacin (Zymar)FDA Link 11/2021 - 09/2003
5	CytokinesIBA 11/2016 - 10/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 01/2011
2	Dihydrotachysterol (AT 10)IBA 01/2021 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 11/2016 - 08/2009
2	Vancomycin FDA LinkGeneric 09/2011 - 04/2008
2	ChemokinesIBA 01/2011 - 10/2008
2	Moxifloxacin (Avelox)FDA Link 04/2009 - 09/2003
1	CXC ChemokinesIBA 11/2021
1	immune inhibitor AIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 10/2020
1	NucleotidesIBA 10/2020
1	Superoxide DismutaseIBA 04/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	kallistatinIBA 01/2020
1	Kallikreins (Kallikrein)IBA 01/2020
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2020
1	Panton-Valentine leukocidinIBA 01/2019
1	S-layer proteinsIBA 01/2019
1	EnzymesIBA 01/2019
1	Methicillin (Metin)FDA Link 01/2019
1	AntitoxinsIBA 01/2019
1	Phenol (Carbolic Acid)FDA Link 01/2019
1	PerforinIBA 11/2017
1	Chemokine CXCL1IBA 11/2016
1	fluorescein isothiocyanate dextranIBA 01/2016
1	Dextrans (Dextran)FDA Link 11/2015
1	Toll-Like Receptor 2IBA 10/2015
1	Toll-Like Receptor 4IBA 10/2015
1	Fluorescein-5-isothiocyanate (FITC)IBA 08/2014
1	Concanavalin AIBA 08/2014
1	Caveolin 1IBA 08/2014
1	Chemotactic FactorsIBA 08/2014
1	LigandsIBA 01/2014
1	Toll-Like Receptor 5IBA 01/2014
1	FlagellinIBA 01/2014
1	Capsules (Microcapsules)IBA 08/2011
1	Chemokine CCL3IBA 08/2009
1	FibrinIBA 08/2009
1	Tight Junction ProteinsIBA 08/2009
1	AlbuminsIBA 08/2009
1	Ophthalmic Solutions (Eye Drops)IBA 04/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2008
1	Peroxidase (Myeloperoxidase)IBA 10/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2007
1	Bacterial ToxinsIBA 09/2005
1	Phosphoinositide Phospholipase CIBA 10/2002
1	phosphatidylcholine-specific phospholipase CIBA 10/2002
1	human AZU1 proteinIBA 05/2002
1	Biological ProductsIBA 05/2002

Therapy/Procedure

12	Therapeutics 11/2021 - 01/2002
3	Intravitreal Injections 01/2021 - 09/2011
2	Vitrectomy 01/2019 - 09/2011
1	Immunomodulation 11/2019
1	Intraocular Injections 01/2019
1	Aftercare (After-Treatment) 09/2011
1	Contact Lenses 07/2010
1	Refractive Surgical Procedures 07/2010